US 8865918
Androgen receptor modulator compounds and methods
granted A61PA61P1/14A61P15/08
Quick answer
US patent 8865918 (Androgen receptor modulator compounds and methods) held by Ligand Pharmaceuticals Incorporated expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P1/14, A61P15/08, A61P15/10, A61P15/16